Human PRPF40B regulates hundreds of alternative splicing targets and represses a hypoxia expression signature.

Human PRPF40B regulates hundreds of alternative splicing targets and represses a hypoxia expression signature. RNA. 2019 May 14;: Authors: Lorenzini PA, Chew RS, Tan CW, Yong JY, Zhang F, Zheng J, Roca X Abstract Altered splicing contributes to the pathogenesis of human blood disorders including MyeloDysplastic Syndromes (MDS) and leukemias. Here we characterized the transcriptomic regulation of PRPF40B, which is a splicing factor mutated in a small fraction of MDS patients. We generated a full PRPF40B knockout in K562 cell line by CRISPR/Cas9 technology, and rescued its levels by transient overexpression of wild-type, P383L or P540S MDS alleles. Using RNA sequencing we identified hundreds of differentially expressed genes and alternative splicing events in the knockout that are rescued by wild-type PRPF40B, with a majority also rescued by MDS alleles, pointing to mild effects of these mutations. Among the PRPF40B-regulated alternative splicing events, we found a net increase in exon inclusion in the knockout, suggesting that this splicing factor primarily acts as a repressor. PRPF40B-regulated splicing events are likely co-transcriptional, affect exons with A-rich downstream intronic motifs and weak splice sites especially for 5' splice sites, consistent with its PRP40 yeast ortholog being part of U1 small nuclear ribonucleoprotein. Loss of PRPF40B in K562 induces a KLF-1 transcriptional signature, genes involved in iron metabolism ...
Source: RNA - Category: Genetics & Stem Cells Authors: Tags: RNA Source Type: research